Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.
Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.
复制标题
DOI:
10.1016/j.jhep.2010.08.007
复制
发表时间:
2011-01
影响因子:
25.7
通讯作者:
Wands JR
中科院分区:
文献类型:
--
作者:
Derdak Z;Lang CH;Villegas KA;Tong M;Mark NM;de la Monte SM;Wands JR
Chronic ethanol consumption in the Long-Evans (LE) rat has been associated with hepatic p53 activation, and inhibition of the insulin/PI3K/AKT signal transduction cascade due to increased expression of phosphatase and tensin homologue deleted on chromosome 10 (PTEN). We hypothesize that p53 activation and altered insulin signaling may influence the susceptibility of rats to ethanol-induced liver damage. Furthermore, p53 not only activates programmed cell death pathways and suppresses hepatocellular survival signals, but promotes gluconeogenesis to increase systemic insulin resistance due to a novel metabolic function. Here, we present evidence that chronic ethanol feeding in Fischer (F), Sprague-Dawley (SD) and LE rats promotes p53 activation, hepatic steatosis, oxidative stress, p53 up-regulated modulator of apoptosis (PUMA) and PTEN expression, which contribute to hepatocellular death and diminished insulin signaling in the liver. Such changes are pronounced in the LE, less prominent in SD, and virtually absent in the F rat strain. More importantly, there is activation of Tp53-induced glycolysis and apoptosis regulator (TIGAR) in the ethanol-fed LE rat. This event generates low hepatic fructose-2, 6-bisphosphate (Fru-2,6-P2) levels, reduced lactate/pyruvate ratio and may contribute to increased basal glucose turnover and high residual hepatic glucose production during euglycemic hyperinsulinemic clamp. Conclusions: p53 activation correlates with the susceptibility to ethanol-induced liver damage in different rat strains. p53 not only orchestrates apoptosis and suppresses cell survival, but by activating TIGAR and decreasing hepatic Fru-2,6-P2 levels it may also promote insulin resistance and therefore, contribute to the metabolic abnormalities associated with hepatic steatosis.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2008.06.006
发表时间:
2008-08-22
影响因子:
3.1
作者:
Lieber, Charles S.;Leo, Maria Anna;DeCarli, Leonore M.
通讯作者:
DeCarli, Leonore M.
影响因子:
8
作者:
Trinei, M;Giorgio, M;Pelicci, PG
通讯作者:
Pelicci, PG
影响因子:
16
作者:
Shimomura, I;Matsuda, M;Goldstein, JL
通讯作者:
Goldstein, JL
影响因子:
25.7
作者:
Pang, Maoyin;de la Monte, Suzanne M.;Wands, Jack R.
通讯作者:
Wands, Jack R.
DOI:
10.1111/j.1440-1746.2008.05339.x
发表时间:
2008-08-01
影响因子:
4.1
作者:
de la Monte, Suzanne M.;Yeon, Jong-Eun;Wands, Jack R.
通讯作者:
Wands, Jack R.